The report "Infection Control Market by Product (Sterilization Equipment: Hydrogen Peroxide, Ethylene, Radiation), Service (ETO, Gamma, E-Beam), Disinfection (Wipes, Disinfector), Gown, Mask, Endoscope Reprocessing, End User (Hospital, Pharma) - Global Forecast to 2030", is projected to reach USD 77.67 billion by 2030 from USD 57.31 billion in 2025, at a CAGR of 6.3%.
Browse 635 market data Tables and 59 Figures spread through 616 Pages and in-depth TOC on "Infection Control Market by Product (Sterilization Equipment: Hydrogen Peroxide, Ethylene, Radiation), Service (ETO, Gamma, E-Beam), Disinfection (Wipes, Disinfector), Gown, Mask, Endoscope Reprocessing, End User (Hospital, Pharma) - Global Forecast to 2030"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/infection-control-market-1084.html
The growth of the infection control market is driven by an increasing number of surgeries and the rising prevalence of healthcare-associated infections. The growing utilization of E-beam and the increasing prevalence of medical devices and pharmaceutical companies are driving market growth. Additionally, the rising trend of outsourcing services among pharmaceutical companies, medical device manufacturers, and hospitals is fueling market growth.
Cleaning & Disinfection products segment is expected to grow at the fastest rate during the forecast period
The infection control market is divided into five main segments based on treatment: sterilization products & services, cleaning & disinfection products, protective barriers, endoscope reprocessing products, and other infection control products. Cleaning and disinfection products are crucial in infection control as they eliminate harmful pathogens from surfaces, equipment, and environments, thereby breaking the chain of infection. These products are widely used across hospitals, laboratories, pharmaceutical facilities, and public spaces to maintain hygiene and prevent cross-contamination. Their frequent and routine application makes them a first line of defense against healthcare-associated infections, supporting regulatory compliance and patient safety. Additionally, their broad applicability, ease of use, and critical role in preventive and corrective infection control measures make them the most widely adopted product category in the market.
Hospitals & Clinics segment is expected to hold the largest share during the forecast period
Based on end user, the infection control market is divided into hospitals & clinics, medical device companies, pharmaceutical companies, the life science industry, and other end users. Among these end users, the hospitals & clinics segment held the largest market share in 2024 for infection control. The hospitals and clinics segment holds the largest share of the infection control market because these facilities face the highest risk of infection transmission due to high patient volumes, frequent invasive procedures, and intensive use of medical devices. They require stringent sterilization, disinfection, and hygiene protocols to prevent healthcare-associated infections and ensure the safety of patients and staff. Additionally, hospitals and clinics must follow strict regulatory guidelines and accreditation standards, which drive ongoing investment in infection prevention products and technologies. Their crucial role in providing medical care makes them the main end users of infection control solutions.
North America is projected to hold the major share of the global infection control market during the forecast period
The infection control market is segmented into six major segments, namely, North America, Europe, Asia Pacific, Latin America, Middle East & Africa, and GCC Countries. North America held the largest market share in the infection control market in 2024, primarily due to its advanced healthcare infrastructure, stringent regulatory standards, and strong emphasis on patient safety. This dominance is expected to continue during the forecast period. High adoption of sterilization and disinfection technologies, rising surgical volumes, and the prevalence of healthcare-associated infections drive consistent demand. Additionally, the presence of leading industry players and substantial healthcare spending further strengthens the region’s market dominance.
Key Players
Prominent players in the infection control market include STERIS (US), Reckitt Benckiser Group plc. (UK), Fortive (US), Sotera Health (US), Solventum (US), Getinge AB (Sweden), Ecolab, Inc. (US), Olympus Corporation (Japan), Envista (US), and PAUL HARTMANN AG (Germany).
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/